Why is Biocon falling/rising?

As of 11-Jul, Biocon Ltd. is currently priced at 373.80, reflecting an increase of 1.8 or 0.48%. Today's price summary indicates that the stock is performing in line with its sector, although it has experienced a significant decline in investor participation, with delivery volume falling by 65.91% compared to the 5-day average. Over the past week, the stock has decreased by 1.67%, while it has shown a positive return of 5.30% over the past month. Despite a year-to-date return of 2.54%, the stock's profits have declined by 7.3% over the past year, which may contribute to investor caution. However, the stock is trading at a discount compared to its peers, and high institutional holdings at 28.46% suggest confidence from more knowledgeable investors, as their stake has increased by 7.07% in the last quarter.
In the broader market context, Biocon's recent performance contrasts with the benchmark Sensex, which has seen a decline of only 1.12% over the past week. While Biocon's short-term performance has lagged behind the benchmark, its longer-term returns of 5.49% over the past year outpace the Sensex's 3.26%. This indicates that while the stock may be facing some short-term challenges, it has shown resilience over a longer period, supported by strong financial metrics such as a high inventory turnover ratio and significant growth in operating profit.